Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (48,217)	$ (144,973)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	17,728	1,103
Stock-based compensation	542	8,633
(Gain)/Loss on disposal on property, plant and equipment	(87)	3,698
Change in fair value of related party notes payable and related party warrant liabilities	7	31,327
Change in fair value of notes payable and warrant liabilities	(27,885)	(79,462)
Change in fair value measurement of earnout liability	0	2,764
Amortization of operating lease right-of-use asset	749	736
Loss on foreign exchange	(2,105)	653
Gain on forgiveness of accounts payable and deposits, net	(518)	0
Non-cash interest expense	0	34
Other	0	661
Changes in operating assets and liabilities:
Deposits	5,955	(12,108)
Inventory	4,804	408
Other current and non-current assets	(1,808)	6,819
Accounts payable	3,559	(11,044)
Financial obligations on sale and lease back transaction	751	0
Accrued expenses and other current liabilities	1,749	(9,626)
Operating lease liabilities	(755)	(542)
Accrued interest expense	5,114	(197)
Net cash used in operating activities	(14,719)	(102,980)
Cash flows from investing activities
Proceeds from sale of equipment	87	0
Purchase of property, plant and equipment	(99)	(16,873)
Net cash used in investing activities	(12)	(16,873)
Cash flows from financing activities
Proceeds from exercise of warrants	0	4,079
Payments of notes payable	0	(6)
Payments of finance lease obligations	0	(335)
Proceeds from exercise of stock options	0	44
Net cash provided by financing activities	12,013	134,443
Effect of exchange rate changes on cash and restricted cash	(2)	170
Net change in cash and restricted cash	(2,720)	14,760
Cash and restricted cash, beginning of period	4,025	18,514
Cash and restricted cash, end of period	1,305	33,274
Cash and restricted cash
Cash	407	31,769
Restricted cash	898	1,505
Total cash and restricted cash	1,305	33,274
Supplemental disclosure of noncash investing and financing activities
Additions of property, plant and equipment included in accounts payable and accrued expenses	45,424	17,249
Issuance of SPA Warrants	1	26,457
Issuance of Secured SPA Notes pursuant to the Exchange Agreement	0	16,500
Reduction in outstanding warrants pursuant to the Exchange Agreement	0	16,506
Reclassification of liability for insufficient authorized shares related to stock options and RSUs	0	8,979
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange	0	6,811
Reclassification of earnout shares liability to equity as part of authorized share increase	0	5,014
Supplemental disclosure of cash flow information
Cash paid for interest	465	324
Nonrelated Party
Supplemental disclosure of noncash investing and financing activities
Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock	9,118	138,180
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	11,403	98,136
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	9,038	131,800
Settlement of notes payable transaction costs	(25)	(1,139)
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	14,295	0
Cash flows from financing activities
Proceeds from related party notes payable	$ 3,000	$ 0